High Net Worth Advisory Group LLC

SEC CIK: 0001919142
Latest filing: Jul 29, 2026

SEC filings (opens in a new tab)

THRX holding history

Theseus Pharmaceuticals, Inc. in every 13F filed by High Net Worth Advisory Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

THRX overview All 13F holders of THRX Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2022

Holdings of THRX by High Net Worth Advisory Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−800−100.0%	Sold out	Holders
Q3 2022	800	$5.00K	<0.1%	00.0%	Unchanged	Holders
Q2 2022	800	$4.00K	<0.1%	−500−38.5%	Reduced	Holders
Q1 2022	1,300	$15.0K	<0.1%	+1,300	New	Holders